The medium chain acyl-CoA dehydrogenase (MCAD) deficiency is the most common enzyme deficiency in fatty acid oxidation. Patients with MCAD deficiency may present clinically as an acute encephalopathy. Apparent life threatening events (ALTEs) have also been reported. During symptomatic episodes, patients may have hypoketotic hypoglycemia. Symptoms are commonly precipitated by metabolic stress such as fasting or infection. An A to G transversion at nucleotide 985 of the cDNA coding region causing the change of amino acid lysine at position 304 to glutamate is the most common mutation in MCAD deficiency accounting for more than 80% of the mutant alleles. Target Analysis for the common mutation (K304E) and sequencing analysis of the entire coding region of the medium-chain acyl-CoA dehydrogenase (ACADM) gene is available on a clinical basis at the Medical Genetics Laboratories at Baylor College of Medicine. Reasons for Referral:
Testing Methodology:Full Sequencing: PCR amplification
of all exons contained in the MCAD gene coding region will be performed
on patients genomic DNA. Direct sequencing of the amplification products
is performed in both the forward and reverse directions using automated
fluorescence dideoxy sequencing methods. Specimen Requirements:Blood: EDTA (purple-top) tubes: Adult: 14 cc; Child: 6 cc; Infant: 2-3 cc Turnaround Time:Full Sequencing: 4 weeks CPT Codes and Prices:Full Sequencing: 83904x24, 83898x12, 83912, 83891 Shipping InformationForms:>> Gene Sequencing Requisition Test Codes:Full Sequencing: 3115 |